Xoma reported $89.61M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1064.23M 241.05M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Chimerix CMRX:US 62.55M 33.25M
Life Technologies LIFE:US $ 103.12M 10.45M
Novartis NOVN:VX 45.72B 19.46B
Prothena PRTA:US 555.62M 29.19M
Xoma XOMA:US $ 89.61M 7.36M